Skip to main content
. Author manuscript; available in PMC: 2017 May 9.
Published in final edited form as: J Allergy Clin Immunol Pract. 2016 Oct 17;5(3):816–818. doi: 10.1016/j.jaip.2016.08.012

Figure 2.

Figure 2

(A) Incidence of immediate hypersensitivity reactions during rapid drug desensitization (RDD) to carboplatin among BRCA positive and negative patients. (B) Grades of rapid drug desensitization reactions (RDD) among BRCA positive and negative patients. (C) Mean tryptase levels in immediate hypersensitivity reactions during rapid drug desensitization (RDD) to carboplatin among BRCA positive and negative patients (normal value < 11.4 μg/L).